Medindia

X

Reportlinker Adds Analytical Tool - Lymphoma

Wednesday, May 25, 2011 General News J E 4
Advertisement

NEW YORK, May 24, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Analytical Tool - Lymphoma

http://www.reportlinker.com/p0284902/Analytical-Tool---Lymphoma.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

Executive Summary

"Analytical Tool: Lymphoma" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in lymphoma R&D and business development. It is also a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding the right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers - A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market and Lymphoma Drug Pipeline Update 2011*.

The Package Includes

- A progress analysis on current and emerging drugs

- Information on most companies active in lymphoma R&D

- Information on key industry related lymphoma projects

- Data from most important clinical trials

- Information on early developmental stage projects

- Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:

- Tracking cutting edge companies, therapies and new technologies

- Rapid identification of partners & competitors

- Laying down a comprehensive framework for further analysis of the field

- Producing presentations surrounding the development of lymphoma therapeutics

- Identifying emerging lymphoma products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of lymphoma drug development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker's software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker's software applications give better overview, specific search capabilities and great dynamic reports.

To order this report:

Pathology Industry: Analytical Tool - Lymphoma

Pathology Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
New Research on Modified Citrus Pectin's Effects A...
S
Reportlinker Adds Triple Analysis: Lymphoma, Melan...